Johnson & Johnson MedTech’s Acclarent business announced FDA 510(k) clearance for its TruDi shaver blade and its advanced navigation features. In a news release posted yesterday, Acclarent described TruDI as a single-use electromagnetically navigated blade. It’s used with the company’s Bien-Air S120 shaver for the incision and removal of soft and hard tissue or bone […]
Johnson & Johnson
6 drug delivery innovations you need to know
From wearable insulin delivery devices to drug-eluting implants and everything in between, drug delivery innovation never stops. Vaccines, life-saving therapeutics, vision-correcting drugs and more are being developed and marketed for delivery with all kinds of technologies. More than a year ago, we compiled a list of eight drug delivery innovations you need to know. With some […]
The biggest medtech personnel moves so far in 2022
In the ever-changing world of medtech, those who are leading the companies are bound to move around a bit. At the end of last year, we compiled a list of medtech’s biggest personnel changes in 2021. So far in 2022, we’ve already seen a slew of major moves involving some of the space’s most powerful […]
J&J focuses on strengthening MedTech business, dampens M&A talk
Johnson & Johnson (NYSE:JNJ) CEO Joaquin Duato says the company isn’t harping on mergers and acquisitions as it grows its MedTech business. Speaking on the company’s second-quarter earnings call, Duato emphasized that Johnson & Johnson MedTech, its rebranded medical devices business, has its sights set on strengthening current strongholds and accessing high-growth market segments to […]
Johnson & Johnson beats The Street in Q2, lowers full-year guidance
Johnson & Johnson (NYSE:JNJ) shares were up before hours on second-quarter results that came in ahead of the consensus forecast. The New Brunswick, New Jersey-based company posted profits of $4.8 billion, or $1.80 per share, on sales of $24 billion for the quarter ended June 2022, for a 23.3% bottom-line slide on sales growth of […]
J&J EVP, general counsel Michael Ullmann set to retire
Johnson & Johnson (NYSE:JNJ) announced today that, after 33 years, Michael Ullmann will retire as EVP and general counsel. Ullmann’s retirement will be made effective on Oct. 17, 2022, at which point Elizabeth Forminard will succeed him as EVP and general counsel, as well as take up a position as a member of Johnson & […]
Moon Surgical raises $31.3M for robotic surgery system
Moon Surgical (Paris and San Francisco) announced today that it has raised $31.3 million in Series A funding to expand its team and accelerate the development of its Maestro robotic surgery system. GT Healthcare Capital & Partners led the round. There was also participation from Johnson & Johnson Innovation – JJDC, Cathay Health — and […]
Ethicon launches next-gen surgical stapler
Johnson & Johnson’s Ethicon today announced the U.S. launch of its next-gen Echelon 3000 stapler. The Echelon 3000 is digitally-enabled and provides surgeons with simple, one-handed powered articulation, according to the Johnson & Johnson (NYSE:JNJ) company. The surgical stapler’s creators designed it with 39% greater jaw aperture and a 27% greater articulation span. The idea […]
FDA clears DePuy Synthes’ Inhance for total shoulder arthroplasty
Johnson & Johnson MedTech’s DePuy Synthes ortho device company announced today that its Inhance system has received FDA clearance for total shoulder arthroplasty. DePuy Synthes officials say their company is first to market with a fully convertible should arthroplasty system. The new clearance is in addition to the system’s already cleared use in anatomic shoulder […]
Johnson & Johnson’s Consumer Health chief to run new stand-alone company
Thibaut Mongon — EVP and Worldwide Chair of Consumer Health at Johnson & Johnson since 2019 — will be CEO of the business when it spins out as a stand-alone company. J&J (NYSE: JNJ) expects the spinoff to be complete in 2023, subject to legal requirements, including consultation with works councils and employee representatives. “Thibaut […]
Johnson & Johnson MedTech appoints new CFO
Johnson & Johnson MedTech (NYSE:JNJ) announced that Kurt Van den Bosch has been appointed as its CFO, group finance. Van den Bosch will be a member of Johnson & Johnson’s global finance team, reporting to the company’s EVP and CFO Joe Wolk. Van den Bosch’s role includes providing financial leadership to the global Johnson & […]
